Upneeq (oxymetazoline hydrochloride ophthalmic solution 0.1%) is a prescription eyedrop used to treat low-lying lids (acquired blepharoptosis) in adults.
LATISSE® is the first prescription product to treat inadequate lashes. It’s clinically proven to deliver lashes that are fuller, longer, and darker at 16 weeks.